Chemed Corp (CHE)
617.95
+1.44
(+0.23%)
USD |
NYSE |
Apr 24, 16:00
592.05
-25.90
(-4.19%)
Pre-Market: 08:47
Chemed Enterprise Value: 9.093B for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 24, 2024 | 9.093B |
April 23, 2024 | 9.072B |
April 22, 2024 | 8.889B |
April 19, 2024 | 8.828B |
April 18, 2024 | 8.783B |
April 17, 2024 | 8.885B |
April 16, 2024 | 8.973B |
April 15, 2024 | 9.062B |
April 12, 2024 | 9.102B |
April 11, 2024 | 9.106B |
April 10, 2024 | 9.133B |
April 09, 2024 | 9.202B |
April 08, 2024 | 9.171B |
April 05, 2024 | 9.279B |
April 04, 2024 | 9.265B |
April 03, 2024 | 9.333B |
April 02, 2024 | 9.379B |
April 01, 2024 | 9.436B |
March 28, 2024 | 9.456B |
March 27, 2024 | 9.491B |
March 26, 2024 | 9.396B |
March 25, 2024 | 9.499B |
March 22, 2024 | 9.559B |
March 21, 2024 | 9.486B |
March 20, 2024 | 9.454B |
Date | Value |
---|---|
March 19, 2024 | 9.588B |
March 18, 2024 | 9.563B |
March 15, 2024 | 9.532B |
March 14, 2024 | 9.578B |
March 13, 2024 | 9.527B |
March 12, 2024 | 9.485B |
March 11, 2024 | 9.545B |
March 08, 2024 | 9.431B |
March 07, 2024 | 9.578B |
March 06, 2024 | 9.370B |
March 05, 2024 | 9.377B |
March 04, 2024 | 9.307B |
March 01, 2024 | 9.031B |
February 29, 2024 | 9.217B |
February 28, 2024 | 9.258B |
February 27, 2024 | 8.771B |
February 26, 2024 | 8.799B |
February 23, 2024 | 8.789B |
February 22, 2024 | 8.772B |
February 21, 2024 | 8.650B |
February 20, 2024 | 8.611B |
February 16, 2024 | 8.572B |
February 15, 2024 | 8.589B |
February 14, 2024 | 8.509B |
February 13, 2024 | 8.395B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.217B
Minimum
May 01 2019
9.588B
Maximum
Mar 19 2024
7.477B
Average
7.482B
Median
May 03 2021
Enterprise Value Benchmarks
Amedisys Inc | 3.299B |
Addus HomeCare Corp | 1.609B |
Regional Health Properties Inc | 74.22M |
OptimizeRx Corp | 188.94M |
Option Care Health Inc | 6.045B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 90.05M |
Revenue (Quarterly) | 585.91M |
Total Expenses (Quarterly) | 477.70M |
EPS Diluted (Quarterly) | 5.90 |
Gross Profit Margin (Quarterly) | 38.84% |
Profit Margin (Quarterly) | 15.37% |
Earnings Yield | 2.90% |
Operating Earnings Yield | 3.65% |
Normalized Earnings Yield | 2.900 |